All‐cause and cause‐specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

BACKGROUND: Mortality is increased in rheumatoid arthritis (RA), mainly because of cardiovascular (CV) events, cancer and infections. Recent data suggest that treatment with tumour necrosis factor (TNF) antagonists may affect this trend. OBJECTIVE: To assess whether treatment with TNF antagonists is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Carmona, Loreto, Descalzo, Miguel Ángel, Perez‐Pampin, Eva, Ruiz‐Montesinos, Dolores, Erra, Alba, Cobo, Tatiana, Gómez‐Reino, Juan J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2007
Konular:
Extended Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955107/
https://ncbi.nlm.nih.gov/pubmed/17324968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.067660
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller